Pulse Biosciences, Inc.
PLSENasdaqCIK 1625101HealthcareFiscal year ends Dec 31
Reports and events: 257 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1412:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032601 |
| 2026-10-0713:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032271 |
| 2026-09-1520:44 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-030456 |
| 2026-09-1512:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030392 |
| 2026-08-0621:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-026351 |
| 2026-08-0620:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026288 |
| 2026-08-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026256 |
| 2026-07-2913:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024758 |
| 2026-06-1220:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-020464 |
| 2026-06-1012:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-020085 |
| 2026-05-1413:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016897 |
| 2026-05-1322:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-222151 |
| 2026-05-1113:17 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001437749-26-016006 |
| 2026-05-0613:05 ET | 8-K | 8.01 Other events | 0001437749-26-015039 |
| 2026-05-0413:16 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014547 |
| 2026-04-3020:11 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-014203 |
| 2026-04-2713:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-013383 |
| 2026-04-1613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012498 |
| 2026-04-0913:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011831 |
| 2026-04-0712:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-011546 |
| 2026-03-2720:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-010105 |
| 2026-03-1712:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-008511 |
| 2026-03-1213:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-007839 |
| 2026-03-0913:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-007283 |
| 2026-03-0321:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-006629 |
| 2026-03-0214:21 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-006269 |
| 2026-02-2722:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-006141 |
| 2026-02-1921:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-004739 |
| 2026-02-1921:09 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-004726 |
| 2026-02-1921:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-004724 |
| 2026-02-0600:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003256 |
| 2026-01-1414:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001225 |
| 2026-01-0914:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-000938 |
| 2025-12-1814:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038213 |
| 2025-12-1221:04 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-037727 |
| 2025-12-0921:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037255 |
| 2025-11-1314:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034658 |
| 2025-11-0521:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033354 |
| 2025-11-0521:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033348 |
| 2025-10-2814:19 ET | DEF 14A | Proxy statementPeriod 2025-12-09 | 0001437749-25-031837 |
| 2025-10-2412:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-031680 |
| 2025-10-1013:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030816 |
| 2025-10-0120:06 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001437749-25-030184 |
| 2025-09-0820:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028560 |
| 2025-09-0322:09 ET | DEF 14A | Proxy statementPeriod 2025-09-30 | 0001437749-25-028189 |
| 2025-09-0213:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028093 |
| 2025-08-2613:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-027725 |
| 2025-08-1220:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026209 |
| 2025-08-1220:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026195 |
| 2025-07-1420:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-022675 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.